Grabar Law Office

1650 Market Street, Suite 3600, Philadelphia, PA 19103, US

SPECIALIZING IN ANTITRUST, SECURITIES, AND CONSUMER CLASS ACTION LITIGATION. OFFERING CLIENTS EXPERT LEGAL ADVICE AND VALUE-ADDED SOLUTIONS.

Recent News

Shareholder Notice to Long-Term Shareholders of Moderna, Inc. (MRNA)

Philadelphia, Pennsylvania--(Newsfile Corp. - November 3, 2024) - Grabar Law Office is investigating whether officers and directors of Moderna, Inc. (NASDAQ: MRNA) breached their fiduciary duties owed to the company. If you have held Moderna shares since prior to January 18, 2023, and would like to learn more about the investigation, your rights, and potential for recovery, please visit https://grabarlaw.com/the-latest/Moderna-Shareholder-Investigation/, contact Joshua Grabar at...

2024-11-03 12:27 PM EST

Attention Long-Term Equinix, Inc. (EQIX) Shareholders: Grabar Law Office Investigates Breach of Fiduciary Duties Claims

Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Grabar Law Office is investigating whether the officers and directors of Equinix, Inc. (NASDAQ: EQIX) violated their fiduciary duties by manipulating financials and misleading investors. Long-term shareholders can seek corporate reforms, reimbursement of corporate funds spent defending litigation, and court-approved incentive awards, at no cost to them whatsoever. Have You Held Equinix Shares Since Before May 3, 2019? If you...

2024-11-01 8:37 AM EDT

InnovAge Holding Corp (INNV) Shareholder Alert: Grabar Law Office Investigates Claims as Securities Fraud Class Action Moves Forward

Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Attention InnovAge (NASDAQ: INNV) shareholders: Grabar Law Office is investigating claims of securities fraud as key allegations against InnovAge and its leadership survive a critical motion to dismiss. If you have continuously held InnovAge shares since its on or near its March 4, 2021 IPO, this is your opportunity to take action. The Class Action Survives the Motion to Dismiss: InnovAge touted its revolutionary approach to...

2024-11-01 8:14 AM EDT

Attention Ocugen, Inc. (OCGN) Shareholders: Grabar Law Office Investigates Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Grabar Law Office is actively investigating potential breaches of fiduciary duty by Ocugen, Inc. (NASDAQ: OCGN) officers and directors. This investigation could lead to significant financial recovery opportunities for long-term shareholders. Why This Matters: On April 1, 2024, Ocugen filed a Notification of Late Filing with the SEC, revealing accounting errors related to collaboration agreements. These errors led to a...

2024-11-01 8:13 AM EDT

Notice to Long-Term Inari (NARI) Shareholders: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Have You Held Inari Medical Shares Continuously Since Before February 24, 2022? Learn More About Your Rights at No Cost to You. Visit https://grabarlaw.com/the-latest/inari-shareholder-investigation/ or contact Joshua H. Grabar at jgrabar@grabarlaw.com or call 267-507-6085. Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches at Inari Medical, Inc. (NASDAQ: NARI) on behalf of long-term...

2024-11-01 8:09 AM EDT

Notice to Akero Therapeutics, Inc. (AKRO) Shareholders: Grabar Law Office Is Investigating Claims of Misconduct on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Grabar Law Office is investigating potential breach of fiduciary duties by Akero Therapeutics, Inc. (NASDAQ: AKRO). If you have held Akero shares since prior to September 13, 2022, you may have the right to: Demand corporate reforms to improve governance. Recover funds expended by the company defending class action litigation. Receive a court-approved incentive award, all at no cost to you. Learn More Today - Visit htt

2024-11-01 8:06 AM EDT

Attention Long-Term Shareholders of Cutera, Inc. (CUTR): Grabar Law Office Is Investigating Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Current Cutera, Inc. (NASDAQ: CUTR) shareholders who have held shares of the Company's stock since at least March 1, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award if appropriate, at no cost to them whatsoever. Click here to learn more: https://grabarlaw.com/the-latest/cutera-shareholder-investigation/. Grabar Law Office is investigating whether certain officers...

2024-11-01 8:01 AM EDT

Methode Electronics, Inc. (MEI) Shareholder Notice: Grabar Law Office Is Investigating Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - November 1, 2024) - Current Methode Electronics, Inc (NYSE: MEI) shareholders who have held Methode shares since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Click here to learn more: https://grabarlaw.com/the-latest/methode-shareholder-investigation/ Grabar Law Office is investigating claims on behalf of Methode Electronics...

2024-11-01 7:59 AM EDT

Alert: Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Extreme Networks, Inc. (EXTR)

Philadelphia, Pennsylvania--(Newsfile Corp. - October 28, 2024) - Shareholders who have held Extreme Networks (NASDAQ: EXTR) stock since on or before July 27, 2022 should visit https://grabarlaw.com/the-latest/extreme-networks-shareholder-investigation/. You can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to you. WHY: Grabar Law Office is investigating claims on behalf of Extreme Networks...

2024-10-28 8:14 AM EDT

Notice to Long-Term Shareholders of Methode Electronics, Inc. (MEI): Grabar Law Office Is Investigating Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - October 28, 2024) - Current Methode Electronics, Inc (NYSE: MEI) shareholders who have held Methode shares since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Click here to learn more: https://grabarlaw.com/the-latest/methode-shareholder-investigation/ Grabar Law Office is investigating claims on behalf of Methode Electronics...

2024-10-28 7:31 AM EDT

Attention Long-term Driven Brands Holdings Inc. (DRVN) Shareholders: Grabar Law Office Is Investigating Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - October 25, 2024) - Grabar Law Office is conducting an investigation on behalf of long-term shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN). The investigation focuses on whether certain officers of the company breached their fiduciary duties, potentially harming the company and its shareholders. Shareholders who have held Driven Brands shares continuously since before October 27, 2021, may have the right to pursue corporate reforms,...

2024-10-25 8:40 AM EDT

Attention Long-Term Inari (NARI) Shareholders: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf

Philadelphia, Pennsylvania--(Newsfile Corp. - October 18, 2024) - Have You Held Inari Medical Shares Continuously Since Before February 24, 2022? Learn More About Your Rights at No Cost to You. Visit https://grabarlaw.com/the-latest/inari-shareholder-investigation/. Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches at Inari Medical, Inc. (NASDAQ: NARI). If you have held Inari shares since prior to February 24, 2022, you may be able to seek: Corporate...

2024-10-18 8:22 AM EDT

InnovAge Holding Corp (INNV) Shareholder Alert: Grabar Law Office Investigates Claims on Behalf of Shareholders as Class Action Survives Motion to Dismiss

Philadelphia, Pennsylvania--(Newsfile Corp. - October 18, 2024) - If you have held InnovAge (NASDAQ: INNV) shares since on or around its March 4, 2021 IPO and would like to learn more about the investigation, your rights, and potential for recovery, please visit https://grabarlaw.com/the-latest/innovage-shareholder-investigation/ contact Joshua Grabar at jgrabar@grabarlaw.com or call 267-507-6085. WHY: Claims alleged in a securities fraud class action complaint against InnovAge (NASDAQ: INNV)...

2024-10-18 8:13 AM EDT

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Extreme Networks, Inc. (EXTR)

Philadelphia, Pennsylvania--(Newsfile Corp. - October 18, 2024) - Grabar Law Office is investigating claims on behalf of Extreme Networks, Inc. (NASDAQ: EXTR) shareholders. The investigation concerns whether certain officers of Extreme Networks have breached their fiduciary duties owed to the company. Shareholders who have held Extreme Networks stock since on or before July 27, 2022 should visit https://grabarlaw.com/the-latest/extreme-networks-shareholder-investigation/. You can seek...

2024-10-18 7:59 AM EDT

ATTENTION AKERO THERAPEUTICS, INC. (AKRO) SHAREHOLDERS: GRABAR LAW OFFICE IS INVESTIGATING CLAIMS OF POSSIBLE MISCONDUCT ON YOUR BEHALF

Philadelphia, Pennsylvania--(Newsfile Corp. - October 14, 2024) - Grabar Law Office is investigating potential breach of fiduciary duties by Akero Therapeutics, Inc. (NASDAQ: AKRO). If you have held Akero shares since prior to September 13, 2022, you may have the right to: Demand corporate reforms to improve governance. Recover funds expended by the company defending class action litigation. Receive a court-approved incentive award, all at no cost to you. Learn More Today: https:

2024-10-14 9:20 AM EDT

SHAREHOLDER ALERT: GRABAR LAW OFFICE INVESTIGATES INTEGRA LIFESCIENCES HOLDINGS CORPORATION (IART)

Philadelphia, Pennsylvania--(Newsfile Corp. - October 14, 2024) - Grabar Law Office is investigating alleged corporate misconduct at Integra LifeSciences Holdings Corporation (NASDAQ: IART). If you have held Integra shares since before March 11, 2019, you may have the right to: Demand corporate reforms to improve governance. Recover funds spent by company defending class action litigation. Receive a court-approved incentive award, all at no cost to you. Learn more today:

2024-10-14 9:18 AM EDT

SHAREHOLDER ALERT: GRABAR LAW OFFICE IS INVESTIGATING POSSIBLE MISCONDUCT AT INARI MEDICAL, INC. (NARI)

Philadelphia, Pennsylvania--(Newsfile Corp. - October 14, 2024) - Grabar Law Office is investigating potential securities fraud and fiduciary duty breaches at Inari Medical, Inc. (NASDAQ: NARI). If you have held Inari shares since prior to February 24, 2022, you may be entitled to: Corporate reforms to protect your investment. Reimbursement of funds to the company's coffers. A court-approved incentive award-all at no cost to you. Learn More at:

2024-10-14 9:11 AM EDT

ATTENTION EQUINIX, INC. SHAREHOLDERS: GRABAR LAW OFFICE INVESTIGATES BREACH OF FIDUCIARY DUTIES CLAIMS

Philadelphia, Pennsylvania--(Newsfile Corp. - October 14, 2024) - Grabar Law Office is investigating whether the officers and directors of Equinix, Inc. (NASDAQ: EQIX) violated their fiduciary duties by manipulating financials and misleading investors. Long-term shareholders can seek corporate reforms, reimbursement of corporate funds spent defending litigation, and court-approved incentive awards. Have You Held Equinix Shares Since Before May 3, 2019? If you have owned Equinix shares since...

2024-10-14 9:06 AM EDT

Grabar Law Office Continues to Investigate Claims on Behalf of Long-Term Shareholders of Verrica Pharmaceuticals, Inc. (VRCA)

Philadelphia, Pennsylvania--(Newsfile Corp. - October 8, 2024) - Current Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA) shareholders who have held Verrica shares since prior to May 19, 2021, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Click here to learn more: https://grabarlaw.com/the-latest/verrica-shareholder-investigation/ Why: On September 3, 2024, a Federal Court issued an Order denying Verrica...

2024-10-08 9:40 AM EDT

Shareholder Alert: Grabar Law Office Is Investigating Claims on Behalf of Long-Term Holders of Inari Medical, Inc. (NARI)

Philadelphia, Pennsylvania--(Newsfile Corp. - October 8, 2024) - Current Inari Medical, Inc. (NASDAQ: NARI) shareholders who have held shares of the Company's stock since prior to February 24, 2022, can seek corporate reforms, the return of funds back to company coffers, and a court approved incentive award if appropriate, at no cost to them whatsoever. Click here to learn more: https://grabarlaw.com/the-latest/inari-shareholder-investigation/. WHY: An underlying securities fraud class action...

2024-10-08 9:16 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us